Celery seed extract is an oral botanical supplement used for blood pressure and metabolic health. Clinical trials strongly support lowering elevated blood pressure, with moderate evidence for reducing uric acid, anxiety, and depressive symptoms and improving female sexual function. Triglycerides decline without cholesterol or lasting blood sugar benefits. Short-term adverse event rates match placebo, alongside allergy, sunlight skin reaction, drug interaction, and rodent male fertility risks. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Seated or 24-hour ambulatory blood pressure (SBP / DBP) | No established target; track reduction from the individual's own baseline | Marker the intervention is expected to change (efficacy) and safety check against hypotension |
| Serum uric acid | 3.5–7.2 mg/dL (208–428 µmol/L) in men; 2.6–6.0 mg/dL (155–357 µmol/L) in women (standard reference range) | Marker the intervention is expected to change via xanthine oxidase (XO) inhibition |
| Fasting serum triglycerides (TG) | No established target; track reduction from the individual's own baseline | Marker the intervention is expected to change |
| Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) | ALT: 7–56 U/L; AST: 8–33 U/L (standard reference range) | Safety check for reactive 3nB sulfate metabolite stress and marker of hepatic response |
| Serum creatinine and blood urea nitrogen (BUN) | Creatinine: 0.6–1.3 mg/dL; BUN: 7–20 mg/dL (standard reference range) | Safety check for renal clearance of 3nB metabolites and marker improved in hypertensive trials |
Cadence: Baseline 7-day home seated/standing blood-pressure log (or 24-hour ambulatory monitor) and fasting morning blood draw; home seated/standing blood pressure recorded daily for the first 2 weeks and weekly thereafter; fasting lab panel repeated at 4 weeks, 12 weeks, and every 6 months.